Cubist Systematic Strategies, LLC Dexcom Inc Transaction History

Cubist Systematic Strategies, LLC

$20.3 Billion
Q2 2025

A detailed history of Cubist Systematic Strategies, LLC transactions in Dexcom Inc stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 12,900 shares of DXCM stock, worth $864,945. This represents 0.01% of its overall portfolio holdings.

Number of Shares

12,900

Previous 332,755 96.12%

Holding current value

$864,945

Previous $22.7 Million 95.04%

% of portfolio

0.01%

Previous 0.15%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$67.74 - $90.75 $19.5 Million - $26.1 Million	287,392 Added 633.54%	332,755 $22.7 Million
Q4 2024 Feb 14, 2025	BUY	$65.68 - $81.01 $2.98 Million - $3.67 Million	45,363 New	45,363 $3.53 Million
Q1 2024 May 15, 2024	SELL	$114.22 - $140.1 $11.8 Million - $14.5 Million	-103,424 Reduced 76.06%	32,558 $4.52 Million
Q4 2023 Feb 14, 2024	SELL	$75.49 - $124.16 $333,816 - $549,035	-4,422 Reduced 3.15%	135,982 $16.9 Million
Q3 2023 Nov 14, 2023	SELL	$86.06 - $137.93 $2.17 Million - $3.48 Million	-25,211 Reduced 15.22%	140,404 $13.1 Million
Q2 2023 Aug 14, 2023	SELL	$112.47 - $130.98 $2.04 Million - $2.38 Million	-18,159 Reduced 9.88%	165,615 $21.3 Million
Q1 2023 May 15, 2023	SELL	$104.0 - $122.92 $4.21 Million - $4.97 Million	-40,452 Reduced 18.04%	183,774 $21.4 Million
Q4 2022 Feb 14, 2023	BUY	$84.98 - $122.67 $10.3 Million - $14.9 Million	121,669 Added 118.64%	224,226 $25.4 Million
Q3 2022 Nov 14, 2022	SELL	$76.35 - $94.18 $8.98 Million - $11.1 Million	-117,645 Reduced 53.43%	102,557 $8.26 Million
Q2 2022 Aug 15, 2022	BUY	$67.99 - $132.89 $14.6 Million - $28.5 Million	214,659 Added 3872.61%	220,202 $16.4 Million
Q1 2022 May 16, 2022	SELL	$94.08 - $130.2 $3.49 Million - $4.83 Million	-37,127 Reduced 87.01%	5,543 $2.84 Million
Q4 2021 Feb 14, 2022	BUY	$129.87 - $162.82 $5.1 Million - $6.39 Million	39,274 Added 1156.48%	42,670 $22.9 Million
Q3 2021 Nov 15, 2021	SELL	$106.71 - $143.18 $1.83 Million - $2.46 Million	-17,149 Reduced 83.47%	3,396 $1.86 Million
Q2 2021 Aug 16, 2021	BUY	$80.99 - $107.93 $1.64 Million - $2.19 Million	20,286 Added 7832.43%	20,545 $8.77 Million
Q1 2021 May 17, 2021	SELL	$84.79 - $104.74 $1.13 Million - $1.39 Million	-13,290 Reduced 98.09%	259 $93,000
Q4 2020 Feb 16, 2021	BUY	$78.0 - $104.5 $291,798 - $390,934	3,741 Added 38.14%	13,549 $5.01 Million
Q3 2020 Nov 16, 2020	SELL	$95.51 - $112.95 $3.32 Million - $3.93 Million	-34,810 Reduced 78.02%	9,808 $4.04 Million
Q2 2020 Aug 14, 2020	SELL	$62.68 - $105.34 $455,056 - $764,768	-7,260 Reduced 13.99%	44,618 $18.1 Million
Q1 2020 May 15, 2020	SELL	$47.79 - $75.63 $1.73 Million - $2.74 Million	-36,184 Reduced 41.09%	51,878 $14 Million
Q4 2019 Feb 14, 2020	BUY	$36.62 - $57.29 $2.81 Million - $4.4 Million	76,791 Added 681.31%	88,062 $19.3 Million
Q3 2019 Nov 14, 2019	SELL	$35.53 - $43.8 $65,517 - $80,767	-1,844 Reduced 14.06%	11,271 $1.68 Million
Q2 2019 Aug 14, 2019	SELL	$27.84 - $38.92 $28,229 - $39,464	-1,014 Reduced 7.18%	13,115 $1.97 Million
Q1 2019 May 15, 2019	SELL	$28.07 - $38.18 $387,394 - $526,922	-13,801 Reduced 49.41%	14,129 $1.68 Million
Q4 2018 Feb 14, 2019	BUY	$26.99 - $37.37 $155,030 - $214,653	5,744 Added 25.89%	27,930 $3.35 Million
Q3 2018 Nov 14, 2018	BUY	$23.35 - $36.72 $401,760 - $631,804	17,206 Added 345.5%	22,186 $3.17 Million
Q2 2018 Aug 14, 2018	BUY	$17.54 - $25.22 $69,809 - $100,375	3,980 Added 398.0%	4,980 $473,000
Q1 2018 May 15, 2018	SELL	$13.06 - $18.54 $42,431 - $60,236	-3,249 Reduced 76.47%	1,000 $74,000
Q4 2017 Feb 14, 2018	BUY	$11.12 - $15.38 $20,727 - $28,668	1,864 Added 78.16%	4,249 $244,000
Q3 2017 Nov 14, 2017	BUY	$11.36 - $18.98 $27,093 - $45,267	2,385	2,385 $117,000

Others Institutions Holding DXCM

# of Institutions

1,108

Shares Held

370M

Call Options Held

5.32M

Put Options Held

5.18M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $25.9B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account

Cubist Systematic Strategies, LLC Dexcom Inc Transaction History